A Randomized, Single Blind Trial to Assess the Effectiveness of Maintaining Patency and Safety of the Vascular Wrap Paclitaxel-Eluting Mesh After Surgical Implantation With the Lifespan ePTFE [expanded polytetrafluoroethylene] Vascular Graft in the Upper Extremity for Hemodialysis Vascular Access.

Trial Profile

A Randomized, Single Blind Trial to Assess the Effectiveness of Maintaining Patency and Safety of the Vascular Wrap Paclitaxel-Eluting Mesh After Surgical Implantation With the Lifespan ePTFE [expanded polytetrafluoroethylene] Vascular Graft in the Upper Extremity for Hemodialysis Vascular Access.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 16 Nov 2011

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Thrombosis
  • Focus Therapeutic Use
  • Sponsors Angiotech Pharmaceuticals
  • Most Recent Events

    • 16 Nov 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 22 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 31 Jul 2008 The expected completion date for this trial is now 1 Apr 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top